Literature DB >> 30928418

Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.

Congxiang Shao1, Junzhao Ye1, Fuxi Li1, Shiting Feng2, Wei Wang3, Bihui Zhong4.   

Abstract

BACKGROUNDS: Non-obese nonalcoholic fatty liver disease (NAFLD) is paradoxically associated with improved metabolic and pathological features at diagnosis but worse prognosis relative to obese NAFLD. AIM: To compare predictors of disease severity in NAFLD with different body mass index (BMI) categories.
METHODS: All 1509 consecutive NAFLD patients were classified as lean (20.2%), overweight (23.1%) and obese (56.7%). Liver fat content (LFC) and fibrosis were estimated with magnetic resonance imaging-based proton density fat fraction and shear wave elastography respectively.
RESULTS: Lipid profiles and uric acid (UA) were significantly increased in parallel with BMI categories (pairwise comparison P < 0.001), but insulin resistance (IR) was significantly different between the non-obese and obese groups. For LFC ≥ 10%, increased waist circumference (WC) was an independent predictor in all groups, while UA elevation (P = 0.02) was predictive in the overweight patients, but BMI ≥ 28 kg/m2 (P = 0.029) and IR (P = 0.026) were significant in the obese patients. For fibrosis, alanine aminotransferase (ALT) > 40 U/L (P = 0.031), increased WC (P = 0.012) and BMI ≥ 28 kg/m2 (P < 0.001) plus ALT > 40 U/L (P = 0.007) were predictors in the lean, overweight and obese patients, respectively.
CONCLUSIONS: WC was strongly predictive of disease severity in all NAFLD, while UA and BMI plus IR were additional predictors in the overweight and obese NAFLD respectively. Individualized screening strategies should be established for NAFLD according to different BMIs.
Copyright © 2019 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body mass index; Liver fat content; Liver fibrosis; Waist circumference

Mesh:

Substances:

Year:  2019        PMID: 30928418     DOI: 10.1016/j.dld.2019.02.019

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  8 in total

1.  The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study.

Authors:  Ping-Fang Hu; Xin Zeng; Zi-Yuan Zou; Wei Tang; Yi-Bin Guo; Zong-Li Yuan; Pei-Mei Shi; Yu Tan; Yan Song; Yong-Quan Shi; Wei-Fen Xie
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

2.  Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study.

Authors:  Aruhan Yang; Xiaoxue Zhu; Lei Zhang; Yingwen Zhang; Dezhi Zhang; Meishan Jin; Junqi Niu; Huimao Zhang; Yanhua Ding; Guoyue Lv
Journal:  Hepatol Int       Date:  2022-07-12       Impact factor: 9.029

3.  The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus.

Authors:  Yuxian Yang; Shuting Li; Yuechao Xu; Jing Ke; Dong Zhao
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-11       Impact factor: 3.249

4.  Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis.

Authors:  Maria Lorena; Mattia Bellan; Maia Lepore; Daniele Sola; Roberta Pedrazzoli; Cristina Rigamonti; Carla De Benedittis; Giulia Francesca Manfredi; Antonio Acquaviva; Stelvio Tonello; Manuela Rizzi; Rosalba Minisini; Mario Pirisi; Pier Paolo Sainaghi
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

5.  Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.

Authors:  Tingfeng Wu; Junzhao Ye; Congxiang Shao; Fuxi Li; Yansong Lin; Qianqian Ma; Wei Wang; Shiting Feng; Bihui Zhong
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-26       Impact factor: 5.555

6.  The Additive Values of the Classification of Higher Serum Uric Acid Levels as a Diagnostic Criteria for Metabolic-Associated Fatty Liver Disease.

Authors:  Jie He; Junzhao Ye; Yanhong Sun; Shiting Feng; Youpeng Chen; Bihui Zhong
Journal:  Nutrients       Date:  2022-08-31       Impact factor: 6.706

7.  Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns.

Authors:  Liu Lei; Wang Changfa; Wang Jiangang; Chen Zhiheng; Yuan Ting; Zhu Xiaoling; Deng Yuling; Wang Yaqin
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

Review 8.  NAFLD in normal weight individuals.

Authors:  Johanna K DiStefano; Glenn S Gerhard
Journal:  Diabetol Metab Syndr       Date:  2022-03-24       Impact factor: 5.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.